Weici Wang
Impact in
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Sulfur Compounds in Biology
Papers in
- Surgery 6
- Infectious Aortic and Vascular Conditions 2
-
- Electrospun Nanofibers in Biomedical Applications 5
- Silk-based biomaterials and applications 3
- Co-authors
- Ke Hu (5 shared papers)Chuanqi Cai (6 shared papers)Ken Ling (4 shared papers)Yi Guo (3 shared papers)Yiqing Li (10 shared papers)Dawei Ye (2 shared papers)Yuxuan Li (1 shared paper)Yuxuan Li (7 shared papers)
- Journals
- Frontiers in Cardiovascular Medicine (2 papers)Frontiers in Public Health (1 paper)Antioxidants (1 paper)Biomolecules (1 paper)BioMed Research International (1 paper)
- Partner nations
- ChinaUnited StatesMaldives
In The Last Decade
Weici Wang
19 papers receiving 321 citations
Peers
Comparison fields: 5 of 78
- Infectious Diseases 66
- Biochemistry 26
- Biomaterials 47
- Neurology 40
- Emergency Medical Services 17
Countries citing papers authored by Weici Wang
This map shows the geographic impact of Weici Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weici Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weici Wang more than expected).
Fields of papers citing papers by Weici Wang
This network shows the impact of papers produced by Weici Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weici Wang. The network helps show where Weici Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Weici Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 98 | |
| 2 | 2022 | 46 | |
| 3 | 2022 | 37 | |
| 4 | 2019 | 24 | |
| 5 | 2012 | 17 | |
| 6 | 2020 | 17 | |
| 7 | 2020 | 16 | |
| 8 | 2022 | 15 | |
| 9 | 2016 | 13 | |
| 10 | 2014 | 7 | |
| 11 | Long non-coding RNA MVIH promotes cell proliferation, migration, invasion through regulating multiple cancer-related pathways, and correlates with worse prognosis in pancreatic ductal adenocarcinomas. | 2020 | 7 |
| 12 | 2022 | 7 | |
| 13 | 2009 | 6 | |
| 14 | 2023 | 4 | |
| 15 | 2009 | 3 | |
| 16 | 2024 | 2 | |
| 17 | 2015 | 2 | |
| 18 | 2019 | 2 | |
| 19 | [Acute phase reaction of different macromolecule vascular grafts healing in rat muscle]. | 2010 | 2 |
| 20 | 2023 | 0 |
About Weici Wang
Weici Wang is a scholar working on Surgery, Biomaterials, Molecular Biology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, having authored 22 papers that have together received 325 indexed citations. Recurring topics across this work include Electrospun Nanofibers in Biomedical Applications (5 papers), Central Venous Catheters and Hemodialysis (4 papers), Silk-based biomaterials and applications (3 papers), Polymer Surface Interaction Studies (2 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Infectious Aortic and Vascular Conditions (2 papers), Sulfur Compounds in Biology (2 papers) and Dialysis and Renal Disease Management (2 papers). The work is most often cited by research in Infectious Diseases (66 citations), Biochemistry (26 citations), Biomaterials (47 citations), Neurology (40 citations) and Emergency Medical Services (17 citations). Weici Wang has collaborated with scholars based in China, United States and Maldives. Frequent co-authors include Ke Hu, Chuanqi Cai, Ken Ling, Yi Guo, Yiqing Li, Dawei Ye, Yuxuan Li, Yuxuan Li, Hongjun Yang and Yi Guo. Their work appears in journals such as Frontiers in Cardiovascular Medicine, Frontiers in Public Health, Antioxidants, Biomolecules and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.